BIRC5 and myeloid sarcoma: As well, an overexpression of survivin in T cells from active MS patients compared with stable MS patients has been reported that correlated with cellular resistance to apoptosis as well as with disease activity manifestations, including the number of enhanced lesions and disease duration [16].